Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. ERYTECH Pharma S.A.
  6. News
  7. Press Releases
    ERYP   FR0011471135

ERYTECH PHARMA S.A.

(ERYP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société ERYTECH PHARMA S.A.
10/05ERYTECH PHARMA S A : Announces Maximum Tolerated Dose Declared in a Phase 1 Investigator S..
PU
10/05ERYTECH PHARMA S A : Announces maximum tolerated dose declared in a phase 1 investigator s..
AQ
10/04ERYTECH PHARMA S A : Announces Maximum Tolerated Dose Declared in a Phase 1 Investigator S..
AQ
09/28ERYTECH PHARMA S A : to Participate in the HealthTech Innovation Days (HTID) by France Bio..
AQ
09/22ERYTECH PHARMA S A : Announces the Availability of its Half-Year Financial Report 2021
AQ
09/21ERYTECH PHARMA S A : ▪TRYbeCA-1, Phase 3 trial of eryaspase in second-line metastati..
PU
09/20ERYTECH PHARMA S A : Provides Business Update and Reports Financial Results for the First ..
AQ
09/20ERYTECH PHARMA S A : I.CERTIFICATION OF THE PERSON RESPONSIBLE FOR THE HALF-YEAR FINANCIAL..
PU
09/17ERYTECH PHARMA S A : to Host on September 21, 2021 Second Quarter 2021 conference call and..
PU
09/15ERYTECH PHARMA S A : to Host on September 21, 2021 Second Quarter 2021 conference call and..
AQ
09/06ERYTECH PHARMA S A : to Present at the H.C. Wainwright 23rd Annual Global Investment Confe..
GL
09/03ERYTECH PHARMA S A : Webinar on Eryaspase in Pancreatic Cancer (September 1, 2021)
PU
08/30ERYTECH PHARMA S A : to Participate in the Citi 16th Annual BioPharma Conference
GL
08/24ERYTECH PHARMA S A : Hosting Key Opinion Leader Webinar on Eryaspase in Pancreatic Cancer
GL
07/30ERYTECH PHARMA S A : ▪Fast Track designation for eryaspase underscores the need for ..
PU
07/29ERYTECH PHARMA S A : Granted U.S. FDA Fast Track Designation for Eryaspase in Hypersensiti..
GL
07/28ERYTECH PHARMA S A : To participate in the btig virtual biotechnology conference
AQ
07/27ERYTECH PHARMA S A : to Participate in the BTIG Virtual Biotechnology Conference
AQ
07/26ERYTECH PHARMA S A : Confirms Plans To Submit BLA for Eryaspase in Hypersensitive ALL Pati..
PU
07/21ERYTECH PHARMA S A : Confirms Plans To Submit BLA for Eryaspase in Hypersensitive ALL Pati..
PU
07/21ERYTECH PHARMA S A : Confirms Plans To Submit BLA for Eryaspase in Hypersensitive ALL Pati..
GL
06/29ERYTECH PHARMA S A : REPORT - ERYTECH'S COMBINED SHAREHOLDERS' MEETING ON JUNE 25, 2021 (F..
PU
06/25ERYTECH PHARMA S A : Report - Erytech's Combined Shareholders' Meeting on June 25, 2021
AQ
06/25ERYTECH PHARMA S A : Report - Erytech's Combined Shareholders' Meeting on June 25, 2021
GL
05/26ERYTECH PHARMA : to Participate in Upcoming Virtual Investor Conferences in June
GL
05/26ERYTECH PHARMA : Availability of the preparatory documents for the Shareholders' Meeting (..
PU
05/06ERYTECH PHARMA : Provides Business Update and Reports Financial Results for the First Quar..
PU
05/05ERYTECH PHARMA : Provides business update and reports financial results for the first quar..
AQ
05/04ERYTECH PHARMA : Provides Business Update and Reports Financial Results for the First Quar..
GL
05/04ERYTECH PHARMA : Registered Direct Offering
PU
05/03ERYTECH PHARMA : Reports Cash Balance at End of Q1 2021 and Announces the Details of its 2..
PU
04/28ERYTECH PHARMA : Reports Cash Balance at End of Q1 2021 and Announces the Details of its 2..
GL
04/19ERYTECH PHARMA : Announces Completion of First Cohort in a Phase 1 Investigator Sponsored ..
GL
04/07ERYTECH PHARMA : to Participate in Upcoming Virtual Investor Conferences in April
GL
03/09ERYTECH PHARMA : Announces Filing of 2020 Universal Registration Document and 2020 Annual ..
GL
03/05ERYTECH PHARMA : to Host Fourth Quarter and Full Year 2020
AQ
03/04ERYTECH PHARMA : to Host Fourth Quarter and Full Year 2020 Conference Call and Business Up..
GL
02/24ERYTECH PHARMA : to Participate in Upcoming Virtual Investor Conferences in March
GL
02/10ERYTECH PHARMA : to Present at the 2021 BIO CEO & Investor Conference
GL
02/08ERYTECH PHARMA : Announces TRYbeCA-1 Phase 3 Trial in 2L Pancreatic Cancer to Continue to ..
PU
01/06ERYTECH PHARMA : to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
GL
01/04ERYTECH PHARMA : to Present at the LifeSci Partners 10th Annual Healthcare Corporate Acces..
GL
2020ERYTECH PHARMA : Completes Enrollment in TRYbeCA-1 Phase 3 Trial in Second-Line Pancreatic..
AQ
2020ERYTECH Completes Enrollment in TRYbeCA-1 Phase 3 Trial in Second-Line Pancreatic Canc..
GL
2020ERYTECH PHARMA : to Present at the JMP Securities Hematology Summit
AQ
2020ERYTECH PHARMA : to Present at the JMP Securities Hematology Summit
GL
2020ERYTECH PHARMA : Announces Positive Results from Eryaspase Phase 2 Trial in Acute Lymphobl..
GL
2020ERYTECH PHARMA : Announces Conference Webcast to Discuss Results from Eryaspase Phase 2 Tr..
AQ
2020ERYTECH PHARMA : Announces Conference Webcast to Discuss Results from Eryaspase Phase 2 Tr..
GL
2020ERYTECH PHARMA : to Present at Jefferies Virtual Healthcare Conference
AQ
2020ERYTECH PHARMA : to Present at Jefferies Virtual Healthcare Conference
AQ
2020ERYTECH PHARMA : to Present at Jefferies Virtual Healthcare Conference
GL
2020ERYTECH to Present at Jefferies Virtual Healthcare Conference
GL
2020ERYTECH PHARMA : Provides Business Update and Reports Financial Results for the Third Quar..
AQ
2020ERYTECH PHARMA : Provides Business Update and Reports Financial Results for the Third Quar..
AQ
2020ERYTECH PHARMA : Provides Business Update and Reports Financial Results for the Third Quar..
GL
2020ERYTECH Provides Business Update and Reports Financial Results for the Third Quarter of..
GL
2020ERYTECH PHARMA : Announces Abstract with Results from Eryaspase Phase 2 Trial in Acute Lym..
AQ
2020ERYTECH PHARMA : Announces Abstract with Results from Eryaspase Phase 2 Trial in Acute Lym..
AQ
2020ERYTECH PHARMA : Announces Abstract with Results from Eryaspase Phase 2 Trial in Acute Lym..
GL
2020ERYTECH Announces Abstract with Results from Eryaspase Phase 2 Trial in Acute Lymphobla..
GL
2020ERYTECH PHARMA : Secures €10 Million in Non-Dilutive Financing, Guaranteed by the French G..
AQ
2020ERYTECH PHARMA : Secures €10 Million in Non-Dilutive Financing, Guaranteed by the French G..
AQ
2020ERYTECH PHARMA : Secures €10 Million in Non-Dilutive Financing, Guaranteed by the French G..
GL
2020ERYTECH Secures €10 Million in Non-Dilutive Financing, Guaranteed by the French Governm..
GL
2020ERYTECH PHARMA : to Host Third Quarter 2020 Conference Call and Business Update on Novembe..
AQ
2020ERYTECH PHARMA : to Host Third Quarter 2020 Conference Call and Business Update on Novembe..
AQ
2020ERYTECH PHARMA : to Host Third Quarter 2020 Conference Call and Business Update on Novembe..
GL
2020ERYTECH to Host Third Quarter 2020 Conference Call and Business Update on November 6, 2..
GL
2020ERYTECH PHARMA : Appoints Stewart Craig as Chief Technical Officer
AQ
2020ERYTECH PHARMA : Appoints Stewart Craig as Chief Technical Officer
AQ
2020ERYTECH PHARMA : Appoints Stewart Craig as Chief Technical Officer
AQ
2020ERYTECH PHARMA : Appoints Stewart Craig as Chief Technical Officer
GL
2020ERYTECH Appoints Stewart Craig as Chief Technical Officer
GL
2020ERYTECH PHARMA : establishes a financing facility with the implementation of an at-the-mar..
AQ
1  2  3Next
Upcoming event on ERYTECH PHARMA S.A.